FDA Recalls Riverpoint Pharmacy Injection Due to Sterility Concerns
First Pharma Associates LLC dba Riverpoint Pharmacy is recalling PAP/PHEN/PGE1 Injection due to a lack of assurance of sterility. The product was distributed in Idaho and Washington.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in an injectable medication, which poses a significant risk of serious injury or infection.
Plain-English summary
First Pharma Associates LLC dba Riverpoint Pharmacy is voluntarily recalling specific lots of PAP/PHEN/PGE1 30 mg/0.83mg/10mcg/mL Injection, 5 mL, Rx only. The recall was initiated because of a lack of assurance of sterility in the product.
The affected product is identified by Lot # 06122019@9 with an expiration date of 07/28/2019. This prescription-only medication was distributed only in Idaho and Washington.
Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- PAP/PHEN/PGE1 30 mg/0.83mg/10mcg/mL Injection, 5 mL, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
- Category
- Drug — Injectable
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 06122019@9
- Exp. 07/28/2019
Distribution
Part of a larger recall action
This product is one of 18 recalled by First Pharma Associates LLC dba Riverpoint Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 18 products in this recall →Related recalls
Same manufacturer · First Pharma Associates LLC dba Riverpoint Pharmacy
See all →- SevereHydroxocobalamin Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-07-17
- SevereMethylcobalamin Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-07-17
- HighTestosterone Cypionate Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-07-17
- SevereRiverpoint Pharmacy Recalls Chorionic Gonadotropin Injection Due to Sterility Concerns
FDA (Drugs) · 2019-07-17
- SevereRiverpoint Pharmacy Recalls Testosterone Cyp/Estradiol Cyp Injection Due to Sterility Concerns
FDA (Drugs) · 2019-07-17
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29